Synthamin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Leucine; Isoleucine; Lysine; Valine; Phenylalanine; Histidine; Threonine; Methionine; Tryptophan; Alanine; Arginine; Glycine; Proline; Serine; Tyrosine.
Product ID | 0338-9575_75add2d7-10de-49b8-92cf-7bc4db0faf56 |
NDC | 0338-9575 |
Product Type | Human Prescription Drug |
Proprietary Name | Synthamin |
Generic Name | Leucine, Isoleucine, Lysine, Valine, Phenylalanine, Histidine, Threonine, Methionine, Tryptophan, Alanine, Arginine, Glycine, Proline, Serine, Tyrosine |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2017-11-03 |
Marketing Category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE / UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | LEUCINE; ISOLEUCINE; LYSINE; VALINE; PHENYLALANINE; HISTIDINE; THREONINE; METHIONINE; TRYPTOPHAN; ALANINE; ARGININE; GLYCINE; PROLINE; SERINE; TYROSINE |
Active Ingredient Strength | 7 g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL; mg/1000mL |
Pharm Classes | Amino Acid [EPC],Amino Acids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-11-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | Unapproved drug for use in drug shor |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-11-03 |
Marketing End Date | 2020-06-30 |
Ingredient | Strength |
---|---|
LEUCINE | 7.3 g/1000mL |
SPL SET ID: | 3d0063d8-d404-4d4a-abff-8b1adf510042 |
Manufacturer | |
UNII |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SYNTHAMIN 73135836 1090673 Dead/Cancelled |
Baxter Travenol Laboratories, Inc. 1977-07-29 |